High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

By A. Ferreri, M. Reni, M. Foppoli, M. Martelli, G. A. Pangalis, M. Frezzato, M. Cabras, A. Fabbri, G. Corazzelli, F. Ilariucci and 22 more. The Lancet, 2009

599 citations recorded by the source corpus.

Subfields: Neurology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/4416910c73a7fb4f74309dd046ab9aa41c7dd7b5